Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566394771> ?p ?o ?g. }
- W1566394771 endingPage "1224" @default.
- W1566394771 startingPage "1221" @default.
- W1566394771 abstract "Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease resulting in systemic microvascular thrombosis. The disease is caused by excessive platelet (PLT) adhesion to ultra-large (UL) von Willebrand factor (VWF) multimers inadequately cleaved by the processing enzyme ADAMTS-13. While many cases respond to plasma exchange performed with or without concurrent corticosteroids, treatment of the 10% to 20% of patients with refractory disease is difficult. Experimental studies demonstrating that N-acetylcysteine (NAC) inhibits PLT binding to endothelial cell-secreted and anchored UL VWF multimers suggest that NAC may be useful in the treatment of TTP.A 44-year-old woman presented with malaise, confusion, chest and abdominal pain, and transient visual loss. Laboratory results and peripheral blood smear were consistent with TTP. The patient was begun on plasma exchange and corticosteroid treatment, but after 10 days the PLT count was still less than 10.0 × 10(9) /L and she developed a fever. Rituximab was initiated, but the patient's condition worsened and she became comatose. Antibiotics were initiated, but cultures remained sterile. After 3 days of coma and further clinical deterioration, treatment with NAC was begun. The patient received a loading dose of 150 mg/kg NAC intravenously (IV) over 1 hour. Within 18 hours the patient awakened abruptly and began communicating with medical personnel. Plasma exchange, corticosteroids, rituximab, and NAC infusion (150 mg/kg IV over 17 hr daily × 10 days) were continued and by Day 17 the PLT count was more than 50 × 10(9) /L. The patient fully recovered and was discharged on Day 31.This is the first complete report of a TTP patient treated with NAC. NAC was a safe and effective supplementary treatment for refractory TTP in this patient." @default.
- W1566394771 created "2016-06-24" @default.
- W1566394771 creator A5004947863 @default.
- W1566394771 creator A5008386087 @default.
- W1566394771 creator A5021704209 @default.
- W1566394771 creator A5034546231 @default.
- W1566394771 creator A5039455579 @default.
- W1566394771 creator A5051027176 @default.
- W1566394771 creator A5083269764 @default.
- W1566394771 date "2013-10-09" @default.
- W1566394771 modified "2023-10-01" @default.
- W1566394771 title "Treatment of refractory thrombotic thrombocytopenic purpura with<i>N</i>-acetylcysteine: a case report" @default.
- W1566394771 cites W1980805976 @default.
- W1566394771 cites W1982499853 @default.
- W1566394771 cites W1989736884 @default.
- W1566394771 cites W2017957905 @default.
- W1566394771 cites W2038158586 @default.
- W1566394771 cites W2039724947 @default.
- W1566394771 cites W2047521726 @default.
- W1566394771 cites W2096190607 @default.
- W1566394771 cites W2121910371 @default.
- W1566394771 cites W2136594380 @default.
- W1566394771 cites W2153195407 @default.
- W1566394771 cites W2315229770 @default.
- W1566394771 cites W2330386487 @default.
- W1566394771 cites W2334213116 @default.
- W1566394771 cites W2340760838 @default.
- W1566394771 cites W4294829823 @default.
- W1566394771 doi "https://doi.org/10.1111/trf.12440" @default.
- W1566394771 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24117464" @default.
- W1566394771 hasPublicationYear "2013" @default.
- W1566394771 type Work @default.
- W1566394771 sameAs 1566394771 @default.
- W1566394771 citedByCount "54" @default.
- W1566394771 countsByYear W15663947712013 @default.
- W1566394771 countsByYear W15663947712014 @default.
- W1566394771 countsByYear W15663947712015 @default.
- W1566394771 countsByYear W15663947712016 @default.
- W1566394771 countsByYear W15663947712017 @default.
- W1566394771 countsByYear W15663947712018 @default.
- W1566394771 countsByYear W15663947712019 @default.
- W1566394771 countsByYear W15663947712020 @default.
- W1566394771 countsByYear W15663947712021 @default.
- W1566394771 countsByYear W15663947712022 @default.
- W1566394771 countsByYear W15663947712023 @default.
- W1566394771 crossrefType "journal-article" @default.
- W1566394771 hasAuthorship W1566394771A5004947863 @default.
- W1566394771 hasAuthorship W1566394771A5008386087 @default.
- W1566394771 hasAuthorship W1566394771A5021704209 @default.
- W1566394771 hasAuthorship W1566394771A5034546231 @default.
- W1566394771 hasAuthorship W1566394771A5039455579 @default.
- W1566394771 hasAuthorship W1566394771A5051027176 @default.
- W1566394771 hasAuthorship W1566394771A5083269764 @default.
- W1566394771 hasConcept C121332964 @default.
- W1566394771 hasConcept C126322002 @default.
- W1566394771 hasConcept C141071460 @default.
- W1566394771 hasConcept C142424586 @default.
- W1566394771 hasConcept C159654299 @default.
- W1566394771 hasConcept C185592680 @default.
- W1566394771 hasConcept C203014093 @default.
- W1566394771 hasConcept C2776015282 @default.
- W1566394771 hasConcept C2777847592 @default.
- W1566394771 hasConcept C2778004101 @default.
- W1566394771 hasConcept C2778585876 @default.
- W1566394771 hasConcept C2779134260 @default.
- W1566394771 hasConcept C2779394231 @default.
- W1566394771 hasConcept C2779788118 @default.
- W1566394771 hasConcept C2780653079 @default.
- W1566394771 hasConcept C2780868729 @default.
- W1566394771 hasConcept C55493867 @default.
- W1566394771 hasConcept C71924100 @default.
- W1566394771 hasConcept C87355193 @default.
- W1566394771 hasConcept C89560881 @default.
- W1566394771 hasConcept C90924648 @default.
- W1566394771 hasConceptScore W1566394771C121332964 @default.
- W1566394771 hasConceptScore W1566394771C126322002 @default.
- W1566394771 hasConceptScore W1566394771C141071460 @default.
- W1566394771 hasConceptScore W1566394771C142424586 @default.
- W1566394771 hasConceptScore W1566394771C159654299 @default.
- W1566394771 hasConceptScore W1566394771C185592680 @default.
- W1566394771 hasConceptScore W1566394771C203014093 @default.
- W1566394771 hasConceptScore W1566394771C2776015282 @default.
- W1566394771 hasConceptScore W1566394771C2777847592 @default.
- W1566394771 hasConceptScore W1566394771C2778004101 @default.
- W1566394771 hasConceptScore W1566394771C2778585876 @default.
- W1566394771 hasConceptScore W1566394771C2779134260 @default.
- W1566394771 hasConceptScore W1566394771C2779394231 @default.
- W1566394771 hasConceptScore W1566394771C2779788118 @default.
- W1566394771 hasConceptScore W1566394771C2780653079 @default.
- W1566394771 hasConceptScore W1566394771C2780868729 @default.
- W1566394771 hasConceptScore W1566394771C55493867 @default.
- W1566394771 hasConceptScore W1566394771C71924100 @default.
- W1566394771 hasConceptScore W1566394771C87355193 @default.
- W1566394771 hasConceptScore W1566394771C89560881 @default.
- W1566394771 hasConceptScore W1566394771C90924648 @default.
- W1566394771 hasIssue "5" @default.
- W1566394771 hasLocation W15663947711 @default.
- W1566394771 hasLocation W15663947712 @default.